ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-37P9508
Home | Market Reports | Health| Reproductive Health
Global HIV Integrase Strand Transfer Inhibitors INSTI Market Insights and Forecast to 2028
BUY CHAPTERS

Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Research Report 2025

Code: QYRE-Auto-37P9508
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Ltd.
Bristol–Myers Squibb
Cipla Ltd
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
Ipca Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
Laurus Labs
Medisist Pharma
Merck
Mylan NV
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)
Janssen Pharmaceutica (Johnson & Johnson)

HIV Integrase Strand Transfer Inhibitors (INSTI) Market

The global market for HIV Integrase Strand Transfer Inhibitors (INSTI) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for HIV Integrase Strand Transfer Inhibitors (INSTI) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of HIV Integrase Strand Transfer Inhibitors (INSTI) include Adcock Ingram Limited, Affine Formulations Limited, Aurobindo Pharma, Biocon Limited, Bristol-Myers Squibb, Cipla, Emcure Pharmaceuticals, Flamingo Pharmaceuticals Limited, Gilead Sciences, Hetero Drugs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HIV Integrase Strand Transfer Inhibitors (INSTI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Integrase Strand Transfer Inhibitors (INSTI).
The HIV Integrase Strand Transfer Inhibitors (INSTI) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Integrase Strand Transfer Inhibitors (INSTI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Integrase Strand Transfer Inhibitors (INSTI) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of HIV Integrase Strand Transfer Inhibitors (INSTI) Market Report

Report Metric Details
Report Name HIV Integrase Strand Transfer Inhibitors (INSTI) Market
Segment by Type
  • Raltegravir
  • Elvitegravir Combination Drugs
  • Dolutegravir and Its Combination Drug
  • Bictegravir Combination Drug
  • Cabotegravir
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Drug Center
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Adcock Ingram Limited, Affine Formulations Limited, Aurobindo Pharma, Biocon Limited, Bristol-Myers Squibb, Cipla, Emcure Pharmaceuticals, Flamingo Pharmaceuticals Limited, Gilead Sciences, Hetero Drugs, IPCA Laboratories, Janssen Pharmaceutica (Johnson & Johnson), LAURUS Labs, Medisist Pharma, Merck, Mylan, Ranbaxy Pharmaceuticals, Shanghai Desano Pharmaceuticals, ViiV Healthcare (GSK)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of HIV Integrase Strand Transfer Inhibitors (INSTI) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HIV Integrase Strand Transfer Inhibitors (INSTI) Market report?

Ans: The main players in the HIV Integrase Strand Transfer Inhibitors (INSTI) Market are Adcock Ingram Limited, Affine Formulations Limited, Aurobindo Pharma, Biocon Limited, Bristol-Myers Squibb, Cipla, Emcure Pharmaceuticals, Flamingo Pharmaceuticals Limited, Gilead Sciences, Hetero Drugs, IPCA Laboratories, Janssen Pharmaceutica (Johnson & Johnson), LAURUS Labs, Medisist Pharma, Merck, Mylan, Ranbaxy Pharmaceuticals, Shanghai Desano Pharmaceuticals, ViiV Healthcare (GSK)

What are the Application segmentation covered in the HIV Integrase Strand Transfer Inhibitors (INSTI) Market report?

Ans: The Applications covered in the HIV Integrase Strand Transfer Inhibitors (INSTI) Market report are Hospital, Clinic, Drug Center, Others

What are the Type segmentation covered in the HIV Integrase Strand Transfer Inhibitors (INSTI) Market report?

Ans: The Types covered in the HIV Integrase Strand Transfer Inhibitors (INSTI) Market report are Raltegravir, Elvitegravir Combination Drugs, Dolutegravir and Its Combination Drug, Bictegravir Combination Drug, Cabotegravir, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Raltegravir
1.2.3 Elvitegravir Combination Drugs
1.2.4 Dolutegravir and Its Combination Drug
1.2.5 Bictegravir Combination Drug
1.2.6 Cabotegravir
1.2.7 Others
1.3 Market by Application
1.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Perspective (2020-2031)
2.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Growth Trends by Region
2.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Region (2020-2025)
2.2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Region (2026-2031)
2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Dynamics
2.3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Trends
2.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
2.3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
2.3.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue
3.1.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue (2020-2025)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2020-2025)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
3.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio
3.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2024
3.5 Global Key Players of HIV Integrase Strand Transfer Inhibitors (INSTI) Head office and Area Served
3.6 Global Key Players of HIV Integrase Strand Transfer Inhibitors (INSTI), Product and Application
3.7 Global Key Players of HIV Integrase Strand Transfer Inhibitors (INSTI), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Type
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2020-2025)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2026-2031)
5 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Application
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Application (2020-2025)
5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2020-2031)
6.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2020-2031)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2020-2031)
8.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025)
8.4 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2020-2031)
9.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
9.4 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2020-2031)
10.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
10.4 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adcock Ingram Limited
11.1.1 Adcock Ingram Limited Company Details
11.1.2 Adcock Ingram Limited Business Overview
11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.1.4 Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.1.5 Adcock Ingram Limited Recent Development
11.2 Affine Formulations Limited
11.2.1 Affine Formulations Limited Company Details
11.2.2 Affine Formulations Limited Business Overview
11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.2.4 Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.2.5 Affine Formulations Limited Recent Development
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Details
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.3.4 Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.3.5 Aurobindo Pharma Recent Development
11.4 Biocon Limited
11.4.1 Biocon Limited Company Details
11.4.2 Biocon Limited Business Overview
11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.4.4 Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.4.5 Biocon Limited Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.5.4 Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.6.4 Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.6.5 Cipla Recent Development
11.7 Emcure Pharmaceuticals
11.7.1 Emcure Pharmaceuticals Company Details
11.7.2 Emcure Pharmaceuticals Business Overview
11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.7.4 Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.7.5 Emcure Pharmaceuticals Recent Development
11.8 Flamingo Pharmaceuticals Limited
11.8.1 Flamingo Pharmaceuticals Limited Company Details
11.8.2 Flamingo Pharmaceuticals Limited Business Overview
11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.8.4 Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.8.5 Flamingo Pharmaceuticals Limited Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.9.4 Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.9.5 Gilead Sciences Recent Development
11.10 Hetero Drugs
11.10.1 Hetero Drugs Company Details
11.10.2 Hetero Drugs Business Overview
11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.10.4 Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.10.5 Hetero Drugs Recent Development
11.11 IPCA Laboratories
11.11.1 IPCA Laboratories Company Details
11.11.2 IPCA Laboratories Business Overview
11.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.11.4 IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.11.5 IPCA Laboratories Recent Development
11.12 Janssen Pharmaceutica (Johnson & Johnson)
11.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Details
11.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview
11.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.12.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Development
11.13 LAURUS Labs
11.13.1 LAURUS Labs Company Details
11.13.2 LAURUS Labs Business Overview
11.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.13.4 LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.13.5 LAURUS Labs Recent Development
11.14 Medisist Pharma
11.14.1 Medisist Pharma Company Details
11.14.2 Medisist Pharma Business Overview
11.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.14.4 Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.14.5 Medisist Pharma Recent Development
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.15.4 Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.15.5 Merck Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.16.4 Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.16.5 Mylan Recent Development
11.17 Ranbaxy Pharmaceuticals
11.17.1 Ranbaxy Pharmaceuticals Company Details
11.17.2 Ranbaxy Pharmaceuticals Business Overview
11.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.17.4 Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.17.5 Ranbaxy Pharmaceuticals Recent Development
11.18 Shanghai Desano Pharmaceuticals
11.18.1 Shanghai Desano Pharmaceuticals Company Details
11.18.2 Shanghai Desano Pharmaceuticals Business Overview
11.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.18.4 Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.18.5 Shanghai Desano Pharmaceuticals Recent Development
11.19 ViiV Healthcare (GSK)
11.19.1 ViiV Healthcare (GSK) Company Details
11.19.2 ViiV Healthcare (GSK) Business Overview
11.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.19.4 ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
11.19.5 ViiV Healthcare (GSK) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Ltd.
Bristol–Myers Squibb
Cipla Ltd
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
Ipca Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
Laurus Labs
Medisist Pharma
Merck
Mylan NV
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)
Janssen Pharmaceutica (Johnson & Johnson)
List of Tables
 Table 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Raltegravir
 Table 3. Key Players of Elvitegravir Combination Drugs
 Table 4. Key Players of Dolutegravir and Its Combination Drug
 Table 5. Key Players of Bictegravir Combination Drug
 Table 6. Key Players of Cabotegravir
 Table 7. Key Players of Others
 Table 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2020-2025)
 Table 12. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2026-2031)
 Table 14. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends
 Table 15. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
 Table 16. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
 Table 17. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints
 Table 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players (2020-2025)
 Table 20. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2024)
 Table 21. Ranking of Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of HIV Integrase Strand Transfer Inhibitors (INSTI), Headquarters and Area Served
 Table 24. Global Key Players of HIV Integrase Strand Transfer Inhibitors (INSTI), Product and Application
 Table 25. Global Key Players of HIV Integrase Strand Transfer Inhibitors (INSTI), Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2020-2025)
 Table 29. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2026-2031)
 Table 31. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2020-2025)
 Table 33. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2026-2031)
 Table 35. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Adcock Ingram Limited Company Details
 Table 51. Adcock Ingram Limited Business Overview
 Table 52. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 53. Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 54. Adcock Ingram Limited Recent Development
 Table 55. Affine Formulations Limited Company Details
 Table 56. Affine Formulations Limited Business Overview
 Table 57. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 58. Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 59. Affine Formulations Limited Recent Development
 Table 60. Aurobindo Pharma Company Details
 Table 61. Aurobindo Pharma Business Overview
 Table 62. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 63. Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 64. Aurobindo Pharma Recent Development
 Table 65. Biocon Limited Company Details
 Table 66. Biocon Limited Business Overview
 Table 67. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 68. Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 69. Biocon Limited Recent Development
 Table 70. Bristol-Myers Squibb Company Details
 Table 71. Bristol-Myers Squibb Business Overview
 Table 72. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 73. Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 74. Bristol-Myers Squibb Recent Development
 Table 75. Cipla Company Details
 Table 76. Cipla Business Overview
 Table 77. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 78. Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 79. Cipla Recent Development
 Table 80. Emcure Pharmaceuticals Company Details
 Table 81. Emcure Pharmaceuticals Business Overview
 Table 82. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 83. Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 84. Emcure Pharmaceuticals Recent Development
 Table 85. Flamingo Pharmaceuticals Limited Company Details
 Table 86. Flamingo Pharmaceuticals Limited Business Overview
 Table 87. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 88. Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 89. Flamingo Pharmaceuticals Limited Recent Development
 Table 90. Gilead Sciences Company Details
 Table 91. Gilead Sciences Business Overview
 Table 92. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 93. Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 94. Gilead Sciences Recent Development
 Table 95. Hetero Drugs Company Details
 Table 96. Hetero Drugs Business Overview
 Table 97. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 98. Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 99. Hetero Drugs Recent Development
 Table 100. IPCA Laboratories Company Details
 Table 101. IPCA Laboratories Business Overview
 Table 102. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 103. IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 104. IPCA Laboratories Recent Development
 Table 105. Janssen Pharmaceutica (Johnson & Johnson) Company Details
 Table 106. Janssen Pharmaceutica (Johnson & Johnson) Business Overview
 Table 107. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 108. Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 109. Janssen Pharmaceutica (Johnson & Johnson) Recent Development
 Table 110. LAURUS Labs Company Details
 Table 111. LAURUS Labs Business Overview
 Table 112. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 113. LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 114. LAURUS Labs Recent Development
 Table 115. Medisist Pharma Company Details
 Table 116. Medisist Pharma Business Overview
 Table 117. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 118. Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 119. Medisist Pharma Recent Development
 Table 120. Merck Company Details
 Table 121. Merck Business Overview
 Table 122. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 123. Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 124. Merck Recent Development
 Table 125. Mylan Company Details
 Table 126. Mylan Business Overview
 Table 127. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 128. Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 129. Mylan Recent Development
 Table 130. Ranbaxy Pharmaceuticals Company Details
 Table 131. Ranbaxy Pharmaceuticals Business Overview
 Table 132. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 133. Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 134. Ranbaxy Pharmaceuticals Recent Development
 Table 135. Shanghai Desano Pharmaceuticals Company Details
 Table 136. Shanghai Desano Pharmaceuticals Business Overview
 Table 137. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 138. Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 139. Shanghai Desano Pharmaceuticals Recent Development
 Table 140. ViiV Healthcare (GSK) Company Details
 Table 141. ViiV Healthcare (GSK) Business Overview
 Table 142. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
 Table 143. ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025) & (US$ Million)
 Table 144. ViiV Healthcare (GSK) Recent Development
 Table 145. Research Programs/Design for This Report
 Table 146. Key Data Information from Secondary Sources
 Table 147. Key Data Information from Primary Sources
 Table 148. Authors List of This Report


List of Figures
 Figure 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Picture
 Figure 2. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type: 2024 VS 2031
 Figure 4. Raltegravir Features
 Figure 5. Elvitegravir Combination Drugs Features
 Figure 6. Dolutegravir and Its Combination Drug Features
 Figure 7. Bictegravir Combination Drug Features
 Figure 8. Cabotegravir Features
 Figure 9. Others Features
 Figure 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2024 VS 2031
 Figure 12. Hospital Case Studies
 Figure 13. Clinic Case Studies
 Figure 14. Drug Center Case Studies
 Figure 15. Others Case Studies
 Figure 16. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
 Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region: 2024 VS 2031
 Figure 20. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players in 2024
 Figure 21. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2024
 Figure 23. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2020-2031)
 Figure 25. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2020-2031)
 Figure 29. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2020-2031)
 Figure 37. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2020-2031)
 Figure 45. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2020-2031)
 Figure 49. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Adcock Ingram Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 53. Affine Formulations Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 54. Aurobindo Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 55. Biocon Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 56. Bristol-Myers Squibb Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 57. Cipla Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 58. Emcure Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 59. Flamingo Pharmaceuticals Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 60. Gilead Sciences Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 61. Hetero Drugs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 62. IPCA Laboratories Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 63. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 64. LAURUS Labs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 65. Medisist Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 66. Merck Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 67. Mylan Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 68. Ranbaxy Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 69. Shanghai Desano Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 70. ViiV Healthcare (GSK) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Integrase Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transferase Assay Kits Market Research Report 2025
Global Adoptive Cell Transfer Therapy Market Research Report 2024
Global Transfer Aids Market Research Report 2025
Global T Cell Transfer Therapy Market Research Report 2024
Global RNase Inhibitor Market Research Report 2025
Global Raltegravir API Market Research Report 2025
Global IVT Enzymes Market Research Report 2024
Global Bictegravir Market Research Report 2024
Global NAMPT Inhibitors Pipeline Analysis Market Research Report 2024
Global HIV Antiretroviral Drug Market Research Report 2025
Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global EZH2 Inhibitor Market Research Report 2024
Global In Vitro Transcription IVT Enzymes Market Research Report 2024
Global Anti invasive Fungal Infection IFI Drug Market Research Report 2024
Global Industrial Transfer Device Market Research Report 2025
Global HIV Therapy Drug Market Research Report 2025
Global Raltegravir Potassium API Market Research Report 2025
Global Long acting Anti HIV Drug Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions